These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30348731)

  • 1. Adjuvant Thalidomide and Metronomic Chemotherapy for the Treatment of Canine Malignant Mammary Gland Neoplasms.
    DE Campos CB; Lavalle GE; Monteiro LN; Pêgas GRA; Fialho SL; Balabram D; Cassali GD
    In Vivo; 2018; 32(6):1659-1666. PubMed ID: 30348731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.
    Polton G; Finotello R; Sabattini S; Rossi F; Laganga P; Vasconi ME; Barbanera A; Stiborova K; Rohrer Bley C; Marconato L
    Vet Comp Oncol; 2018 Sep; 16(3):399-408. PubMed ID: 29508493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors.
    Lavalle GE; De Campos CB; Bertagnolli AC; Cassali GD
    In Vivo; 2012; 26(3):375-9. PubMed ID: 22523289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel.
    Simon D; Schoenrock D; Baumgärtner W; Nolte I
    J Vet Intern Med; 2006; 20(5):1184-90. PubMed ID: 17063714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of significant adverse events following thalidomide administration in bitches diagnosed with mammary gland carcinomas.
    de Campos CB; Lavalle GE; Fialho Ligório S; Camargo Nunes F; Carneiro RA; Amorim RL; Cassali GD
    Vet Rec; 2016 Nov; 179(20):514. PubMed ID: 27553604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
    Treggiari E; Borrego JF; Gramer I; Valenti P; Harper A; Finotello R; Toni C; Laomedonte P; Romanelli G
    Vet Comp Oncol; 2020 Mar; 18(1):43-51. PubMed ID: 31648405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma.
    Rossi F; Sabattini S; Vascellari M; Marconato L
    Vet Comp Oncol; 2018 Dec; 16(4):497-504. PubMed ID: 29806156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
    Bray JP; Orbell G; Cave N; Munday JS
    J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
    Arenas C; Peña L; Granados-Soler JL; Pérez-Alenza MD
    Vet Rec; 2016 Jul; 179(5):125. PubMed ID: 27377395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
    Marconato L; Lorenzo RM; Abramo F; Ratto A; Zini E
    Vet Comp Oncol; 2008 Jun; 6(2):90-101. PubMed ID: 19178668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasized Leydig cell tumor in a dog.
    Togni A; Rütten M; Bley CR; Hurter K
    Schweiz Arch Tierheilkd; 2015 Feb; 157(2):111-5. PubMed ID: 26753337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy.
    Tran CM; Moore AS; Frimberger AE
    Vet Comp Oncol; 2016 Sep; 14(3):252-62. PubMed ID: 24735412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma.
    Wang-Yuan Z; Jiang-Zheng Z; Lu YD; Hao XB; Hong T; Huang F; Lei JH; He ZH; Huang MZ
    Int J Hyperthermia; 2016; 32(2):193-8. PubMed ID: 26586093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma.
    Finotello R; Henriques J; Sabattini S; Stefanello D; Felisberto R; Pizzoni S; Ferrari R; Marconato L
    Vet Comp Oncol; 2017 Jun; 15(2):493-503. PubMed ID: 26792231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of treatment for mammary gland tumors.
    Novosad CA
    Clin Tech Small Anim Pract; 2003 May; 18(2):107-9. PubMed ID: 12831071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
    Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
    Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
    Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
    J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
    Kerbel RS; Shaked Y
    Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children.
    López-Aguilar E; Sepúlveda-Vildósola AC; Betanzos-Cabrera Y; Rocha-Moreno YG; Gascón-Lastiri G; Rivera-Márquez H; Wanzke-del-Angel V; Cerecedo-Díaz F; de la Cruz-Yañez H
    Arch Med Res; 2008 Oct; 39(7):655-62. PubMed ID: 18760193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.